Adam S. Cheifetz

The Incidence and Management of Infusion Reactions To Infliximab: A Large Center Experience

Adam S. Cheifetz, Michelle V. Smedley, S Bogetz Martin et al. · The American Journal of Gastroenterology · 2003 · 489 citations

Life Sciences, Immunology, Pharmacotherapy +14

Functional variants in the <i>LRRK2</i> gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease

Ken Hui, Heriberto Fernandez-Hernandez, Jianzhong Hu et al. · Science Translational Medicine · 2018 · 408 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Adam S. Cheifetz, Asher Kornbluth, Peter Legnani et al. · The American Journal of Gastroenterology · 2006 · 366 citations

Medicine, Clinical Sciences, Internal Medicine +13

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Konstantinos Papamichael, Adam S. Cheifetz, Gil Melmed et al. · Clinical Gastroenterology and Hepatology · 2019 · 328 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +12

Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab

Konstantinos Papamichael, Karen A. Chachu, Ravy K. Vajravelu et al. · Clinical Gastroenterology and Hepatology · 2017 · 221 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +14